fda warning letters compounded semaglutide tirzepatide 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of US FDA sends 25 letters

Buse highlighted a significant philosophical shift toward earlier and more routine use of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT-2) inhibitors, noting that the updated guidance explicitly recommends considering these agents from the point of a type 2 diabetes (T2D) diagnosis, given their role as disease-modifying therapies

A Flexible Spending Account (FSA) is similar but is usually offered through an employer

4 minute read Summary GLP-1 medications such as semaglutide (Wegovy), tirzepatide (Zepbound), and compounded liraglutide are clinically proven treatments for weight loss, especially for women experiencing menopause or perimenopause who have struggled with weight management despite lifestyle changes

Brett Brechner, DO, is our medical director

You should work with a qualified provider to discuss your individual risk factors before starting any GLP-1 therapy, including semaglutide from PlexusDx

SYNERGISTIC COMBINATION: CAGRILINTIDE + SEMAGLUTIDE When combined, cagrilintide and semaglutide produce metabolic effects significantly greater than additive